Conflict of Interest in the Debate over Calcium-Channel Antagonists
Open accessAbstract
BACKGROUND: Physicians' financial relationships with the pharmaceutical industry are controversial because such relationships may pose a conflict of interest. It is unknown to what extent industry support of medical education and research influences the opinions and behavior of clinicians and researchers. The recent debate over the safety of calcium-channel antagonists provided an opportunity to examine the effect of financial conflicts of interest. METHODS: We searched the English-language medical literature published from March 1995 through September 1996 for articles examining the controversy about the safety of calcium-channel antagonists. Articles were reviewed and classified as being supportive, neutral, or critical with respect to the use of calcium-channel antagonists. The authors of the articles were asked about their financial relationships with both manufacturers of calcium-channel antagonists and manufacturers of competing products (i.e., beta-blockers, angiotensin-converting-enzyme inhibitors, diuretics, and nitrates). We examined the authors' published positions on the safety of calcium-channel antagonists according to their financial relationships with pharmaceutical companies. RESULTS: Authors who supported the use of calcium-channel antagonists were significantly more likely than neutral or critical authors to have financial relationships with manufacturers of calcium-channel antagonists (96 percent, vs. 60 percent and 37 percent, respectively; P<0.001). Supportive authors were also more likely than neutral or critical authors to have financial relationships with any pharmaceutical manufacturer, irrespective of the product (100 percent, vs. 67 percent and 43 percent, respectively; P< 0.001). CONCLUSIONS: Our results demonstrate a strong association between authors' published positions on the safety of calcium-channel antagonists and their financial relationships with pharmaceutical manufacturers. The medical profession needs to develop a more effective policy on conflict of interest. We support complete disclosure of relationships with pharmaceutical manufacturers for clinicians and researchers who write articles examining pharmaceutical products.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several investigations show strong associations between the source of funding and the conclusions of research articles.
“Several investigations show strong associations between the source of funding and the conclusions of research articles [ 219 – 222 ].”
From Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007) · cites this paper as [221]
Cited by
Sorted by citations
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613 · see citing works
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543 · see citing works
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.07.014 · Cited by 2,969 · see citing works
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2007) · Epidemiology · doi:10.1097/ede.0b013e3181577511 · Cited by 2,779 · see citing works
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman, J. E., Li, Y., & Gross, C. P. (2003) · JAMA · doi:10.1001/jama.289.4.454 · Cited by 1,816 · see citing works
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697 · see citing works
Fostering integrity in research: Definitions, current knowledge, and future directions
Steneck, N. H. (2006) · Science and Engineering Ethics · doi:10.1007/pl00022268 · Cited by 407 · see citing works
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318 · see citing works
A case for a duty to feed the hungry: GM plants and the third world
Carter, L. (2007) · Science and Engineering Ethics · doi:10.1007/s11948-006-0006-y · Cited by 265 · see citing works
Yank, V., Rennie, D., & Bero, L. A. (2007) · BMJ · doi:10.1136/bmj.39376.447211.be · Cited by 235 · see citing works
Degrees of integrity: the threat of corruption in higher education
Chapman, D. W., & Lindner, S. (2016) · Studies in Higher Education · doi:10.1080/03075079.2014.927854 · Cited by 152 · see citing works
Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments
Roseman, M. (2011) · JAMA · doi:10.1001/jama.2011.257 · Cited by 145 · see citing works
Nejstgaard, C. H., Bero, L., Hróbjartsson, A., Jørgensen, A. W., Jørgensen, K. J., Le, M., & Lundh, A. (2020) · BMJ · doi:10.1136/bmj.m4234 · Cited by 116 · see citing works
Hansen, C., Lundh, A., Rasmussen, K., & Hróbjartsson, A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000047.pub2 · Cited by 96 · see citing works
Why do we think we know what we know? A metaknowledge analysis of the salt controversy
Trinquart, L., Johns, D. M., & Galea, S. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv184 · Cited by 77 · see citing works
Gómez-García, F., Ruano, J., Gay-Mimbrera, J., Aguilar-Luque, M., Sanz-Cabanillas, J. L., Alcalde-Mellado, P., Maestre-López, B., Carmona-Fernández, P. J., González-Padilla, M., García-Nieto, A. V., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.08.015 · Cited by 37 · see citing works
Institutional Conflicts of Interest in Academic Research
Resnik, D. B. (2019) · Science and Engineering Ethics · doi:10.1007/s11948-015-9702-9 · Cited by 40 · see citing works
Science and money: problems and solutions
Resnik, D. B. (2014) · Journal of Microbiology & Biology Education · doi:10.1128/jmbe.v15i2.792 · Cited by 33 · see citing works
- Authors
- Stelfox, H. T., Chua, G., O'Rourke, K., & Detsky, A. S.
- Affiliations
- University of Toronto (CA)
- Mount Sinai Hospital (CA)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1998-01-08
- Volume
- 338
- Issue
- 2
- Pages
- 101-106
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2330587574
- Cited by
- 615
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 10 · 2023: 15 · 2022: 6 · 2021: 7 · 2020: 14 · 2019: 6 · 2018: 9 · 2017: 16 · 2016: 17 · 2015: 11 · 2014: 12 · 2013: 16 · 2012: 32
- FWCI
- 34.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
- Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
- Social Sciences › Business, Management and Accounting › Strategy and Management › Political Influence and Corporate Strategies
- Keywords
- conflicts of interest, calcium channel blockers, pharmaceutical industry, financial relations, author disclosure, drug safety controversy, disclosure policy
- MeSH terms
- Calcium Channel Blockers, Drug Industry, Humans, Physicians, Research Support as Topic, Conflict of Interest, Risk Assessment, Disclosure, Editorial Policies, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
